Can we deconstruct cannabis in the lab, reduce costs, and unlock a myriad of new applications and benefits? Here to help us answer this is Benjamin Chiarelli of Cellibre.  Learn more at https://www.cellibre.com  Key Takeaways: [00:51] An inside look at Cellibre, a cellular agriculture company that specializes in cannabis [3:10] Ben’s background and how he came to start Cellibre [8:07] How Cellibre “mimics” the cannabis plant to make cells that create specific isolates [13:02] How price points will shift in the cannabis industry as cannabinoid biosynthesis grows [21:20] The evolution of cellular agriculture and the obstacles it’s faced in commodity industries like cannabis [30:29] Why CBG will be the first product available from cellular agriculture [33:03] Where Cellibre fits into the cannabinoid market [35:51] Why Ben agrees cannabis is “the new vanilla” [41:40] Where Cellibre currently is in the capital-raising process